Christoph T Berger
Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study.
Bielicki I, Schmid H, Atkinson A, Kahlert C, Berger C, Troillet N, Marschall J, Bielicki J, Swissnoso. Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study. Antimicrob Resist Infect Control 2023; 12:106.
25.09.2023Association between perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in paediatric uncomplicated appendectomy: a Swiss retrospective cohort study.
25.09.2023Antimicrob Resist Infect Control 2023; 12:106
Bielicki Isabella, Schmid Hanna, Atkinson Andrew, Kahlert Christian, Berger Christoph T, Troillet Nicolas, Marschall Jonas, Bielicki Julia, Swissnoso
Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.
Mombelli M, Neofytos D, Huynh-Do U, Sánchez-Céspedes J, Stampf S, Golshayan D, Dahdal S, Stirnimann G, Schnyder A, Garzoni C, Venzin R, Magenta L, Schönenberger M, Walti L, Hirzel C, Munting A, Dickenmann M, Koller M, Aubert J, Steiger J, Pascual M, Müller T, Schuurmans M, Berger C, Binet F, Villard J, Müller N, Egli A, Cordero E, Van Delden C, Manuel O, Swiss Transplant Cohort Study. Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial. Clin Infect Dis 2023
16.08.2023Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients: The STOP-FLU trial.
16.08.2023Clin Infect Dis 2023
Mombelli Matteo, Neofytos Dionysios, Huynh-Do Uyen, Sánchez-Céspedes Javier, Stampf Susanne, Golshayan Délaviz, Dahdal Suzan, Stirnimann Guido, Schnyder Aurelia, Garzoni Christian, Venzin Reto M, Magenta Lorenzo, Schönenberger Melanie, Walti Laura N, Hirzel Cédric, Munting Aline, Dickenmann Michael, Koller Michael, Aubert John-David, Steiger Jürg, Pascual Manuel, Müller Thomas F, Schuurmans Macé M, Berger Christoph T, Binet Françoise-Isabelle, Villard Jean, Müller Nicolas J., Egli Adrian, Cordero Elisa, Van Delden Christian, Manuel Oriol, Swiss Transplant Cohort Study
Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
Walti L, Mugglin C, Mombelli M, Manuel O, Hirsch H, Khanna N, Müller N, Berger C, Boggian K, Garzoni C, Neofytos D, Van Delden C, Mäusezahl M, Hirzel C, Swiss Transplant Cohort Study. Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland. JAMA Netw Open 2023; 6:e2310687.
03.04.2023Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
03.04.2023JAMA Netw Open 2023; 6:e2310687
Walti Laura N, Mugglin Catrina, Mombelli Matteo, Manuel Oriol, Hirsch Hans H., Khanna Nina, Müller Nicolas J., Berger Christoph T, Boggian Katia, Garzoni Christian, Neofytos Dionysios, Van Delden Christian, Mäusezahl Mirjam, Hirzel Cédric, Swiss Transplant Cohort Study
Management of giant-cell arteritis in Switzerland: an online national survey.
Iudici M, Hemmig A, Stegert M, Courvoisier D, Adler S, Becker M, Berger C, Dan D, Finckh A, Mahr A, Neumann T, Reichenbach S, Ribi C, Seitz L, Villiger P, Wildi L, Daikeler T, Giant Cell Arteritis SCQM Study Group. Management of giant-cell arteritis in Switzerland: an online national survey. Swiss Med Wkly 2023; 153:40051.
03.04.2023Management of giant-cell arteritis in Switzerland: an online national survey.
03.04.2023Swiss Med Wkly 2023; 153:40051
Iudici Michele, Hemmig Andrea Katharina, Stegert Mihaela, Courvoisier Delphine Sophie, Adler Sabine, Becker Mike Oliver, Berger Christoph T, Dan Diana, Finckh Axel, Mahr Alfred, Neumann Thomas, Reichenbach Stephan, Ribi Camillo, Seitz Luca, Villiger Peter M, Wildi Lukas, Daikeler Thomas D, Giant Cell Arteritis SCQM Study Group
Low secondary attack rate after prolonged exposure to sputum smear positive miliary tuberculosis in a neonatal unit.
Popovici R, Kaelin M, Kuster S, Sax H, Rampini S, Zbinden R, Relly C, Zacek B, Bassler D, Fontijn J, Berger C. Low secondary attack rate after prolonged exposure to sputum smear positive miliary tuberculosis in a neonatal unit. Antimicrob Resist Infect Control 2022; 11:148.
05.12.2022Low secondary attack rate after prolonged exposure to sputum smear positive miliary tuberculosis in a neonatal unit.
05.12.2022Antimicrob Resist Infect Control 2022; 11:148
Popovici Roxana M, Kaelin Marisa B, Kuster Stefan, Sax Hugo, Rampini Silvana K, Zbinden Reinhard, Relly Christa, Zacek Bea, Bassler Dirk, Fontijn Jehudith R, Berger Christoph T
Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland.
Waldeck F, Seiffert S, Manser S, Zemp D, Walt A, Berger C, Albrich W, Schlegel M, Roloff T, Egli A, Nolte O, Kahlert C. Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland. Sci Rep 2022; 12:19826.
18.11.2022Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland.
18.11.2022Sci Rep 2022; 12:19826
Waldeck Frederike, Seiffert Salome N, Manser Susanne, Zemp Danuta, Walt Angela, Berger Christoph T, Albrich Werner, Schlegel Matthias, Roloff Tim, Egli Adrian, Nolte Oliver, Kahlert Christian
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
Raptis C, Berger C, Ciurea A, Andrey D, Polysopoulos C, Lescuyer P, Maletic T, Riek M, Scherer A, von Loga I, Safford J, Lauper K, Möller B, Vuilleumier N, Finckh A, Rubbert-Roth A. Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases. Front Immunol 2022; 13:1016927.
13.10.2022Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
13.10.2022Front Immunol 2022; 13:1016927
Raptis Catherine E, Berger Christoph T, Ciurea Adrian, Andrey Diego O, Polysopoulos Christos, Lescuyer Pierre, Maletic Tanja, Riek Myriam, Scherer Almut, von Loga Isabell, Safford Judith, Lauper Kim, Möller Burkhard, Vuilleumier Nicolas, Finckh Axel, Rubbert-Roth Andrea
Swiss recommendations on perioperative antimicrobial prophylaxis in children.
Paioni P, Aebi C, Bielicki J, Buettcher M, Crisinel P, Kahlert C, Wagner N, Berger C. Swiss recommendations on perioperative antimicrobial prophylaxis in children. Swiss Med Wkly 2022; 152:w30230.
28.09.2022Swiss recommendations on perioperative antimicrobial prophylaxis in children.
28.09.2022Swiss Med Wkly 2022; 152:w30230
Paioni Paolo, Aebi Christoph, Bielicki Julia, Buettcher Michael, Crisinel Pierre Alex, Kahlert Christian, Wagner Noémie, Berger Christoph T
Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients.
van den Bogaart L, Mombelli M, Manuel O, Mueller N, Van Delden C, Pascual M, Berger C, Garzoni C, Boggian K, Walti L, Egli A, Neofytos D, Lang B, Swiss Transplant Cohort Study. Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients. Am J Transplant 2021; 22:199-209.
20.09.2021Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients.
20.09.2021Am J Transplant 2021; 22:199-209
van den Bogaart Lorena, Mombelli Matteo, Manuel Oriol, Mueller Nicolas J, Van Delden Christian, Pascual Manuel, Berger Christoph T, Garzoni Christian, Boggian Katia, Walti Laura N, Egli Adrian, Neofytos Dionysios, Lang Brian M, Swiss Transplant Cohort Study
Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis
Navarini A, Bignucolo O, Meyer B, Meienberg F, Mehling M, Jeker L, Heijnen I, Daikeler T, Gebbers J, Grimbacher B, Sansom D, Jeker R, Hess C, Jauch A, Kistner A, Bigler M, Hruz P, Berger C, Hou T, Schwab C, Gabrysch A, Higgins R, Frede N, Padberg S, Kämpe O, Burgener A, Marquardsen F, Baldin F, Recher M. Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis. J Allergy Clin Immunol 2016; 139:1043-1046.e5.
28.11.2016Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis
28.11.2016J Allergy Clin Immunol 2016; 139:1043-1046.e5
Navarini Alexander A, Bignucolo Olivier, Meyer Benedikt, Meienberg Fabian, Mehling Matthias, Jeker Lukas T, Heijnen Ingmar, Daikeler Thomas D, Gebbers Jan-Olaf, Grimbacher Bodo, Sansom David M, Jeker Raphael, Hess Christoph, Jauch Annaise, Kistner Anne, Bigler Marc, Hruz Petr, Berger Christoph T, Hou Tie Zheng, Schwab Charlotte, Gabrysch Annemarie, Higgins Rebecca, Frede Natalie, Padberg Sgier, Kämpe Olle, Burgener Anne-Valérie, Marquardsen Florian, Baldin Fabian, Recher Mike